Table 4

Baseline characteristics of the two randomised patient groups

Intervention n (%)
(n=57)
Control n (%)
(n=58)
P values
Gender (male)40 (70)48 (83)0.17
Age mean (SD)64.74 (15)63.88 (15)0.76
 Range (min–max)75 (19–94)71 (19–90)
Frequent admissions (yes)19 (33)28 (48)0.11
Difficult to control symptoms (yes)48 (84)48 (83)0.83
Complex care requirements (yes)4 (7)2 (3)0.44
Decline in function (yes)23 (40)22 (38)0.79
Surrogate (yes)43 (75)49 (85)0.23
Clear end-of-life preferences (yes)24 (42)20 (35)0.52
Advance directive (yes)20 (35)18 (31)0.64
Want to be resuscitated0.34
 Yes11 (19)12 (21)
 Yes, depending on the prognosis20 (35)27 (47)
 No26 (46)19 (33)
Ward1.00
 Dermatology5 (9)5 (9)
 Internal medicine5 (9)7 (12)
 Nephrology3 (5)3 (5)
 Neurology5 (9)5 (9)
 Oncology16 (28)16 (28)
 Radio-oncology17 (30)18 (31)
 Haematology6 (11)4 (7)
Religious affiliation (yes)44 (77)46 (79)0.96
Main diagnosis0.43
 Cancer51 (90)49 (85)
 Other6 (11)9 (16)
Highest education0.54
 Lower education3 (5)1 (2)
 Upper education29 (51)33 (57)
 Higher education25 (44)24 (41)
Citizenship0.49
 Swiss48 (84)52 (90)
 EU5 (9)5 (9)
 Other4 (7)1 (2)
Civil status0.28
 In a relationship39 (68)36 (62)
 Single5 (9)11 (19)
 Separated13 (23)11 (19)
  • n=number of patients. SD=standard deviation